Endoscopic vein harvest for coronary artery bypass surgery

Chinese Medical Journal (Taipei)

Volumn 61, Issue 5, 1998, Pages 276-280

  Li, Chui Yang ^a,b   Lai, Shiau Ting ^a   Yu, Tarng Jenn ^a   Wang, Jih Shiuan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Coronary artery bypass graft (CABG); Endopath subcutaneous dissector; Video assisted endoscopic vein harvest

Indexed keywords

AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; ENDOSCOPIC SURGERY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; SAPHENOUS VEIN GRAFT; SURGICAL TECHNIQUE; VIDEORECORDING;

AGED; CORONARY ARTERY BYPASS; ENDOSCOPY; FEMALE; HUMANS; MALE; SAPHENOUS VEIN;

EID: 0031860918     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Penn I. Malignancies following the use of cyclosporine A in man. Cancer Surv 1982;1:621-4.
2. Sheil AGR. Cancer after transplantation. World J Surg 1986;10:389-96.
3. Penn I. Malignancies in organ transplant recipients in cyclosporine era. In: Chatelain C, Jacobs C, eds. Seminaires D'Uro-nephrologie, Pitie-Salpetriere, 18th ed. Paris: Masson, 1992:234-52
4. Department of Health, Excutive Yuan, Republic of China: Cancer Registry Annual Report in Taiwan Area, 1989.
5. Sheil AGR, Disney APS, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993;25:1383-4.
6. Penn I. Immunosuppression and opportunistic tumors: Do viruses play a role? In: Dammaco F, ed. Advances in Tumor Immunology and Allergic Disorders. Immuno Incontri, Vol 6. Milan: Edi Ermes 1992:139-62.
7. Penn I. Malignancy. Surg Clin North Am 1994;74:1247-57.
8. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neo plasms in dialysis patients: a population-based study. Am J Kidney Dis 1989;14:119-23.
9. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML. Urologic cancers in uremic patients. Am J Kidney Dis 1995;25: 694-700.
10. Brunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: the EDTA-ERA registry experience. Nephrol Dial Transplant 1995;10(suppl):74-80.
11. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiologic considerations. Hepatology 1982;2(suppl):21-6.
12. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89: 259-66.
13. Penn I, Brunson ME. Cancers following cyclosporine therapy. Transplant Proc 1988;20:885-92.
14. Penn I. Cancer complicating organ transplantation. New Engl J Med 1990;323:1767-69.
15. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993;7:431-45.
16. Gruber SA, Skjei KL, Sothern RB. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Transplant Proc 1991;23:1104-5.